Ocular Therapeutix
OCUL
OCUL
106 hedge funds and large institutions have $321M invested in Ocular Therapeutix in 2020 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 53 increasing their positions, 9 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
106
Holders Change
+16
Holders Change %
+17.78%
% of All Funds
2.18%
Holding in Top 10
7
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+40%
% of All Funds
0.14%
New
24
Increased
53
Reduced
9
Closed
8
Calls
$4.72M
Puts
$2.18M
Net Calls
+$2.54M
Net Calls Change
+$124K
Top Buyers
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$22.7M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$7.56M |
| 3 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$7.18M |
| 4 |
BlackRock
New York
|
+$6.3M |
| 5 |
ECM
Endurant Capital Management
San Mateo,
California
|
+$6.29M |
Top Sellers
| 1 |
Millennium Management
New York
|
-$8.26M |
| 2 |
SHI
SV Health Investors
Boston,
Massachusetts
|
-$2.63M |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$161K |
| 4 |
Jane Street
New York
|
-$118K |
| 5 |
SI
Stephens Inc
Little Rock,
Arkansas
|
-$111K |
